Slovenian pharma group ups sales in Romania
The sales of the Slovenian pharma group Krka grew by 21% year-on-year in 2014 in Romania, to EUR 61.2 million. They represent 40% of the group’s southeastern European sales, according to a Krka report. The company’s portfolio includes…
Romania Insider · Journalist
· Updated · 1 min read
The sales of the Slovenian pharma group Krka grew by 21% year-on-year in 2014 in Romania, to EUR 61.2 million. They represent 40% of the group’s southeastern European sales, according to a Krka report. The company’s portfolio includes prescription and non-prescription drugs, as well as vet products. In the whole region, Krka sold drugs worth EUR 155.3 million, which represent 13% of its global sales. These amount to EUR 1.19 billion. Krka ranks 10th on the Romanian market, with a 3% market share, according to market analysis company Cegedim. editor@romania-insider.com
